Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biofrontera Inc (NQ: BFRI )

3.750 +0.404 (+12.06%)
Streaming Delayed Price Updated: 3:54 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biofrontera Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Biofrontera Inc. Announces U.S. Patent Issued for Photodynamic Therapy Protocol with Reduced Side Effects
Via ACCESSWIRE
Biofrontera: Q1 Earnings Insights
Via Benzinga
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
Via ACCESSWIRE
Biofrontera Inc. Sponsors The Sun Bus, Delivering Free Mobile Skin Cancer Screenings Across the U.S.
Via ACCESSWIRE
Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz(R)-PDT
Via ACCESSWIRE
Biofrontera Inc. Names Founder and Executive Chairman Hermann Luebbert as Chief Executive Officer
Via ACCESSWIRE
Why Is Biolase (BIOL) Stock Down 13% Today?
Biolase (BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. 
Via InvestorPlace
Why Is Assure (IONM) Stock Down 36% Today?
Assure (IONM) stock is falling on Friday after the medical company released preliminary earnings for the first quarter of 2023. 
Via InvestorPlace
Biofrontera Inc. Announces Resignation of CEO
Via ACCESSWIRE
Biofrontera Earnings Preview
Via Benzinga
Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting
Via ACCESSWIRE
Biofrontera's Earnings Outlook
Via Benzinga
Why Is Getaround (GETR) Stock Up 104% Today?
Getaround (GETR) stock is getting a boost on Friday after the company announced its intention to acquire HyreCar (HYRE). 
Via InvestorPlace
Earnings Scheduled For May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter. 
Via Benzinga
BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates
BFRI stock earnings show Biofrontera missing analyst estimates for earnings per share and revenue for the first quarter. 
Via InvestorPlace
Biofrontera Inc. Announces New Secured Line of Credit up to $6.5 Million
Via ACCESSWIRE
Biofrontera Collaborates with The Skin Cancer Foundation to Raise Awareness of Skin Cancer Prevention
Via ACCESSWIRE
Biofrontera Inc. to Report First Quarter 2023 Financial Results on May 12, 2023
Via ACCESSWIRE
Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz(R)
Via ACCESSWIRE
Biofrontera Inc. Makes Transformative Investment in Its' Dermatology Salesforce
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket
Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
Via ACCESSWIRE
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.